BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 9510257)

  • 1. Medical contraindications are not a major factor in the underutilization of breast conserving therapy.
    Morrow M; Bucci C; Rademaker A
    J Am Coll Surg; 1998 Mar; 186(3):269-74. PubMed ID: 9510257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which eligible breast conservation patients choose mastectomy in the setting of newly diagnosed breast cancer?
    Adkisson CD; Bagaria SP; Parker AS; Bray JM; Gibson T; Thomas CS; Heckman MG; McLaughlin SA
    Ann Surg Oncol; 2012 Apr; 19(4):1129-36. PubMed ID: 21975859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors that influence surgical choices in women with breast carcinoma.
    Staradub VL; Hsieh YC; Clauson J; Langerman A; Rademaker AW; Morrow M
    Cancer; 2002 Sep; 95(6):1185-90. PubMed ID: 12216083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of breast-conserving therapy for younger women with breast cancer.
    Guenther JM; Kirgan DM; Giuliano AE
    Arch Surg; 1996 Jun; 131(6):632-6. PubMed ID: 8645070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Institutional variation in the surgical treatment of breast cancer: a study of the NCCN.
    Greenberg CC; Lipsitz SR; Hughes ME; Edge SB; Theriault R; Wilson JL; Carter WB; Blayney DW; Niland J; Weeks JC
    Ann Surg; 2011 Aug; 254(2):339-45. PubMed ID: 21725233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer: a pooled analysis of updated results.
    Jatoi I; Proschan MA
    Am J Clin Oncol; 2005 Jun; 28(3):289-94. PubMed ID: 15923803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma.
    Pawlik TM; Perry A; Strom EA; Babiera GV; Buchholz TA; Singletary E; Perkins GH; Ross MI; Schecter NR; Meric-Bernstam F; Ames FC; Hunt KK; Kuerer HM
    Cancer; 2004 Feb; 100(3):490-8. PubMed ID: 14745864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standards for diagnosis and management of ductal carcinoma in situ (DCIS) of the breast. American College of Radiology. American College of Surgeons. College of American Pathologists. Society of Surgical Oncology.
    Winchester DP; Strom EA
    CA Cancer J Clin; 1998; 48(2):108-28. PubMed ID: 9522825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast conservation therapy rates are no different in medically indigent versus insured patients with early stage breast cancer.
    Parviz M; Cassel JB; Kaplan BJ; Karp SE; Neifeld JP; Penberthy LT; Bear HD
    J Surg Oncol; 2003 Oct; 84(2):57-62. PubMed ID: 14502777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in the treatment of ductal carcinoma in situ of the breast.
    Baxter NN; Virnig BA; Durham SB; Tuttle TM
    J Natl Cancer Inst; 2004 Mar; 96(6):443-8. PubMed ID: 15026469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equivalent Survival With Mastectomy or Breast-conserving Surgery Plus Radiation in Young Women Aged < 40 Years With Early-Stage Breast Cancer: A National Registry-based Stage-by-Stage Comparison.
    Ye JC; Yan W; Christos PJ; Nori D; Ravi A
    Clin Breast Cancer; 2015 Oct; 15(5):390-7. PubMed ID: 25957740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is radiation indicated in patients with ductal carcinoma in situ and close or positive mastectomy margins?
    Chan LW; Rabban J; Hwang ES; Bevan A; Alvarado M; Ewing C; Esserman L; Fowble B
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):25-30. PubMed ID: 20646871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Survival After Breast-Conserving Therapy vs Mastectomy Among Patients With or Without the BRCA1/2 Variant in a Large Series of Unselected Chinese Patients With Breast Cancer.
    Wan Q; Su L; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
    JAMA Netw Open; 2021 Apr; 4(4):e216259. PubMed ID: 33890992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing patient decision-making between simple mastectomy and surgical alternatives.
    Lee WQ; Tan VKM; Choo HMC; Ong J; Krishnapriya R; Khong S; Tan M; Sim YR; Tan BK; Madhukumar P; Yong WS; Ong KW
    BJS Open; 2019 Feb; 3(1):31-37. PubMed ID: 30734013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment trends for ductal carcinoma in situ of the breast.
    Winchester DP; Menck HR; Osteen RT; Kraybill W
    Ann Surg Oncol; 1995 May; 2(3):207-13. PubMed ID: 7641016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of breast conservation rates: reasons for mastectomy at a comprehensive cancer center.
    Lee MC; Rogers K; Griffith K; Diehl KA; Breslin TM; Cimmino VM; Chang AE; Newman LA; Sabel MS
    Breast J; 2009; 15(1):34-40. PubMed ID: 19141132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients.
    McGuire KP; Santillan AA; Kaur P; Meade T; Parbhoo J; Mathias M; Shamehdi C; Davis M; Ramos D; Cox CE
    Ann Surg Oncol; 2009 Oct; 16(10):2682-90. PubMed ID: 19653046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of neoadjuvant systemic therapy on breast conservation rates in patients with HER2-positive breast cancer: Surgical results from a phase II randomized controlled trial.
    Yamaguchi T; Hozumi Y; Sagara Y; Takahashi M; Yoneyama K; Fujisawa T; Osumi S; Akabane H; Nishimura R; Mieno MN; Mukai H
    Surg Oncol; 2021 Mar; 36():51-55. PubMed ID: 33310293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.
    Hofvind S; Holen Å; Aas T; Roman M; Sebuødegård S; Akslen LA
    Eur J Surg Oncol; 2015 Oct; 41(10):1417-22. PubMed ID: 26253193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.